Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
34 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


RSS FeedsMaxinovel`s Orally Active PD-L1 Inhibitor Demonstrating Similar Efficacy to PD-L1 Antibody Durvalumab
(WorldNews Health)

 
 

20 april 2019 00:48:59

 
Maxinovel`s Orally Active PD-L1 Inhibitor Demonstrating Similar Efficacy to PD-L1 Antibody Durvalumab
(WorldNews Health)
 


SHANGHAI--(BUSINESS WIRE)--Maxinovel Pharmaceuticals, Inc. presented in the 2019 AACR the head to head comparison of its orally active small molecule PD-L1 inhibitor with commercially marketed PD-L1 antibody drug Durvalumab in the human PD-L1 knock-in MC38 cell line in human PD-1 knock-in mice model [LB-018]. These two molecules demonstrated similar tumor growth inhibition (TGI) when they were tested twice. `It is very exciting to know that orally active small molecule PD-L1 inhibitor has simil ......


 
11 viewsCategory: Science > Medicine
 
FDA permits marketing of first medical device for treatment of ADHD
(WorldNews Health)
AHF Urges G20 to Prioritize Public Health; Fully Fund the Global Fund
(WorldNews Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten